Drug intelligence / Profile preview

flopropione

Development stage
Unknown
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral
01

Overview

Flopropione is a phloroglucinol-derived small molecule traditionally used in Japan as an antispasmodic agent for the treatment of biliary and urinary tract disorders. It acts as a catechol-O-methyltransferase (COMT) inhibitor and exhibits musculotropic effects that relax smooth muscle, particularly the sphincter of Oddi. More recently, flopropione has been repositioned for the prevention of cisplatin-induced nephrotoxicity. In this context, it functions as an inhibitor of cysteine conjugate beta-lyase (C-S lyase), an enzyme responsible for metabolizing cisplatin-cysteine conjugates into highly reactive and nephrotoxic thiol compounds. By blocking this bioactivation pathway, flopropione aims to mitigate acute kidney injury in cancer patients receiving cisplatin-based chemotherapy.

Brand names
CospanonCompasLabrodaxMirulevPellegalSpasmex
Other names
2,4,6-trihydroxypropiophenonephloropropiophenonephlorpropiophenone
02

Targets

TRPV3 (Transient receptor potential vanilloid subtype 3)COMT (Catechol-O-methyltransferase)

Beyond the preview

Go deeper on flopropione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flopropione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call